Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.
about
Can tissue-based immune markers be used for studying the natural history of cancer?Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapyγδ T cell and other immune cells crosstalk in cellular immunityHarnessing the power of Vδ2 cells in cancer immunotherapyVaccines versus immunotherapy: overview of approaches in deciding between optionsRandomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerTrial Watch: Experimental Toll-like receptor agonists for cancer therapyRationale for combining immunotherapy with chemotherapy.Immunomodulatory effects of heat-killed Mycobacterium obuense on human blood dendritic cells.Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis.Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity.Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria.Draft Genome Sequence of Mycobacterium obuense Strain UC1, Isolated from Patient Sputum.Tripartite immune cell co-operation in the Bacillus Calmette Guérin-induced activation of γδ T cells.Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity
P2860
Q24605537-62D96D77-392E-40AD-8FB5-439F8A16D0F1Q26781175-70321ED9-1A8A-4297-9D48-3B2388A72753Q27007775-33CC635B-F440-41F8-A0CB-EE049834B1C9Q27027547-7D1C0CD0-16AE-43DF-B44E-4993EE373C0CQ28085434-8565B00E-10BC-43F9-A80E-500F23564200Q34539541-05DB9D4D-381A-4818-97CF-ABB6235D55D0Q36194849-F3E42E25-E00A-43B7-87C8-A19D786CAB5CQ38389326-7E6723BC-FA76-4AA7-B559-FA88B6FB668AQ38602494-086E9321-D264-4373-9273-DF91EB383891Q38986536-58AC14FC-9950-41AF-B3EB-74888BC19766Q39149552-5ACB47AE-812B-41ED-83E6-B83F4FF17C38Q40071474-793E5FCB-4C33-4FC7-BAD0-ECB6AC9B9F4AQ42372846-BA7D6B7E-F316-4D52-9F18-B4AC35722693Q42531756-84C00F7C-CE3B-46AD-AFAF-369707D792C6Q44732034-2FB69590-B8F6-4DF9-A276-55CEC9084E5BQ55025711-F8DFF463-C50A-4EDB-8A36-7B1926F2DFCEQ58782404-9DD1650A-30F2-4DE3-A6AB-405B6AEA2F3E
P2860
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@en
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@nl
type
label
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@en
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@nl
prefLabel
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@en
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@nl
P2093
P2860
P1476
Mycobacteria activate γδ T-cel ...... tion for cancer immunotherapy.
@en
P2093
Angus G Dalgleish
Daniel W Fowler
John Copier
Mark D Bodman-Smith
Natalie Wilson
P2860
P2888
P304
P356
10.1007/S00262-011-1121-4
P577
2011-10-15T00:00:00Z
P5875
P6179
1009568582